AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Black women in U.S. more likely to have delayed diagnosis, treatment.
2004 APR 1 - (NewsRx.com & NewsRx.net) -- A new study finds African American women are more likely than white women to have delays in diagnosis and treatment for breast cancer.
Researchers from The University of Texas M.D. Anderson Cancer Center in collaboration with colleagues from Emory University and the U.S. Centers for Disease Control and Prevention, both in Atlanta, Georgia, say factors such as income, insurance, and the means of detection account for some, but not all, of the race-related delays in breast cancer treatment.
The study was published March 8, 2004, in the online edition of Cancer and will also appear in the April 15, 2004, print edition [Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer, April 15, 2004;100(8)].
Black women in the U.S. are more likely to die of breast cancer than Caucasian women. Access to care, socioeconomic status, and tumor biology are thought to contribute to racial differences in mortality. Whether race itself is associated with a delay in treatment has been scarcely studied and the results are inconsistent. Treatment delays of 3 months or more from the onset of symptoms have been linked to lower rates of survival from breast cancer.
In the first study ...
- Two drinks a day increases risk of breast cancer, study shows.
- Magazine article from: Women's Health Weekly March 4, 2004 700+ words
...MD, founder of The Breast Cancer Care & Research...or hopeful time for breast cancer research and treatment...for their particular breast cancer." This article was prepared by Women's Health Weekly editors from staff...
- Irsogladine side-steps angiogenic function to stop breast cancer metastasis.
- Magazine article from: Women's Health Weekly March 25, 2004 700+ words
...agent, irsogladine. Breast Cancer Res Treat, 2004...publisher of the journal Breast Cancer Research and Treatment...Gastroenterology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Change on enzyme gene may associate with invasive disease.(breast cancer...
- Magazine article from: Women's Health Weekly January 9, 2003 700+ words
...than women without breast cancer carried a polymorphism...MMP-3 * Women whose breast cancer had spread were more...metastasis in women with breast cancer This article was prepared by Women's Health Weekly editors from staff...
- Protein tyrosine phosphatase gamma is a tumor suppressor gene in breast cancer.
- Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...independent growth of breast cancer cells in soft agar...PTP gamma) in human breast cancer cell line MCF-7...Enzymology, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
- Magazine article from: Women's Health Weekly May 6, 2004 700+ words
...Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR...Biotechnology, Oncogenesis and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff and other...
- Older breast cancer patients in Canada benefit from early detection.
- Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...year survival of 2192 breast cancer women diagnosed between...Survival of women with breast cancer in Ottawa, Canada...amp; Mortality, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Gene patterns in the ERBB2/TOP2A region of breast cancer influence outcomes.
- Magazine article from: Women's Health Weekly June 17, 2004 700+ words
...ERBB2/TOP2A region of breast cancer influence outcomes...ERBB2/TOP2A region in breast cancer. Gene Chromosome Cancer...Oncogenesis, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Cystatin M is a novel candidate tumor suppressor gene for breast cancer.
- Magazine article from: Women's Health Weekly December 30, 2004 700+ words
...suppressor gene for breast cancer," Zhang concluded...suppressor gene for breast cancer. Cancer Res, 2004...Suppressor Gene and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Source: HighBeam Research, Black women in U.S. more likely to have delayed diagnosis, treatment.